LexBlog IP

JUNE 30, 2023

Beginning tomorrow, July 1, 2023, CYLTEZO® (adalimumab-adbm) will become the first HUMIRA® (adalimumab) biosimilar with interchangeable status to be commercially available in the United States. Stay tuned to Big Molecule Watch for continued updates on this topic.

Designs 52

Designs Design Branding Brands 52

LexBlog IP

MARCH 17, 2022

This FOA arises out of the FDA’s proposed commitments in the third proposed Biosimilar User Free Act, through which it intends to “explor[e] ways to enhance biosimilar and interchangeable biosimilar product development and regulatory science.”

Intellectual Property 52

Intellectual Property 52

LexBlog IP

APRIL 29, 2022

The testimony spanned many topics, but notably the FDA discussed the progress of biosimilar approvals, including its impact on cost. Since that time, the number has grown to 33 approved biosimilars, including two interchangeable products. decrease in price (for insulin glargine) to a 42.2% decrease in price (for infliximab).

Licensing 52

Licensing Law Intellectual Property 52

Art Law Journal

JANUARY 6, 2022

We cover topics including career paths, preparing for interviews, using social media to grow your footprint, networking, and much more. Creative director” and “Art director” are terms that get thrown around a lot—sometimes interchangeably. Both Creative Circle and Artrepreneur are committed to being here for you throughout your career.

Art 52

Art Graphic Design Social Media Branding 52

43(B)log

AUGUST 9, 2021

5, 2021) Scilex sells an FDA-approved, prescription-strength topical analgesic self-adhesive patch, ZTlido (lidocaine), which is allegedly often prescribed off-label, including for general neuropathic pain (e.g., Scilex Pharmaceuticals Inc. Sanofi-Aventis U.S. LLC, 2021 WL 3417590, F.Supp.3d 3d -, 2021 WL 3417590, No. 21-cv-01280-JST (N.D.

False Advertising 59

False Advertising Advertising Advertising Marketing 59

Art Law Journal

APRIL 21, 2022

We cover topics including career paths, preparing for interviews, using social media to grow your footprint, networking, and much more. They may even be used interchangeably—perhaps because they are one letter apart—but that’s a misconception. UX and UI are often paired together.

Designs 52

Designs Design Art Social Media 52

Patently-O

SEPTEMBER 26, 2022

Topics: Enablement / Written Description (All three are biotech / pharma): 3 Cases; Infringement (FDA Labeling): 1 Case; Anticipation (On Sale Bar): 1 Case; Double Patenting (Still the law?) I have subjectively ordered the cases with the most important or most likely cases toward the top.

Patent Law 125

Patent Law Law Patent Invention 125